PHMB — Pharmacom Biovet Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Pharmacom Biovet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1999 December 31st | 2000 December 31st | 2001 December 31st | 2002 December 31st | 2003 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 0 | 18.2 | 0.311 | 0.556 | 0.16 |
| Operating Profit | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
| Net Income Before Taxes | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0 | -18.2 | -0.311 | -0.556 | -0.16 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0 | -324 | -2.58 | -2.06 | -0.284 |
| Dividends per Share |